- Canada
- /
- Medical Equipment
- /
- TSXV:NSCI
TSX Penny Stocks To Watch In May 2025
As Canadian large-cap stocks recently reached new all-time highs, the market continues to navigate a landscape marked by persistent inflation and softer economic growth. For those investors looking beyond the traditional giants, penny stocks—often representing smaller or newer companies—offer intriguing opportunities. While the term "penny stock" may seem outdated, these investments remain relevant today as they can present hidden value and potential for significant returns when supported by strong financials.
Top 10 Penny Stocks In Canada
Click here to see the full list of 902 stocks from our TSX Penny Stocks screener.
Here's a peek at a few of the choices from the screener.
Metalla Royalty & Streaming (TSXV:MTA)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Metalla Royalty & Streaming Ltd. is a precious metals royalty and streaming company focused on acquiring and managing gold, silver, and copper royalties and streams in Canada, with a market cap of CA$363.50 million.
Operations: Metalla Royalty & Streaming Ltd. has not reported any specific revenue segments.
Market Cap: CA$363.5M
Metalla Royalty & Streaming Ltd., with a market cap of CA$363.50 million, is pre-revenue and currently unprofitable, although it has reduced its net losses over recent years. The company's net debt to equity ratio is satisfactory at 1.6%, and it maintains a sufficient cash runway for over three years based on current free cash flow. Despite short-term liabilities exceeding short-term assets, long-term obligations are covered by existing assets. Recent earnings reports show narrowing losses, suggesting potential operational improvements. Analysts anticipate significant stock price appreciation, though the company remains volatile with stable weekly fluctuations at 7%.
- Get an in-depth perspective on Metalla Royalty & Streaming's performance by reading our balance sheet health report here.
- Gain insights into Metalla Royalty & Streaming's outlook and expected performance with our report on the company's earnings estimates.
New Age Metals (TSXV:NAM)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: New Age Metals Inc. is a mineral exploration company focused on acquiring, exploring, and developing platinum group metals, precious, and base metals properties in Canada and the United States with a market cap of CA$5.83 million.
Operations: New Age Metals Inc. does not currently report any revenue segments.
Market Cap: CA$5.83M
New Age Metals Inc., with a market cap of CA$5.83 million, is pre-revenue and currently unprofitable, experiencing increasing losses over the past five years. The company recently received a Letter of Acceptance for grassroots exploration on its Newfoundland gold-antimony properties, expanding its land holdings to 19,300 hectares. Despite high share price volatility and negative return on equity, NAM remains debt-free with sufficient cash runway for over three years under current free cash flow conditions. Its seasoned management team plans to commence Phase 1 exploration mid-May 2025, aiming to uncover promising mineralized targets in strategic locations.
- Take a closer look at New Age Metals' potential here in our financial health report.
- Evaluate New Age Metals' historical performance by accessing our past performance report.
Nanalysis Scientific (TSXV:NSCI)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products globally, with a market cap of CA$31.14 million.
Operations: The company generates revenue from two main segments: CA$26.10 million from Security Services and CA$19.40 million from Scientific Equipment.
Market Cap: CA$31.14M
Nanalysis Scientific Corp., with a market cap of CA$31.14 million, reported revenues of CA$45.5 million for 2024, reflecting growth from the previous year. Despite this revenue increase, the company remains unprofitable with a net loss of CA$13.61 million and faces auditor concerns regarding its ability to continue as a going concern. The launch of its advanced 60 MHz Benchtop NMR spectrometer aims to capture demand across various industries by offering enhanced capabilities at competitive pricing. While short-term assets cover both short and long-term liabilities, the high net debt to equity ratio indicates financial leverage challenges amidst ongoing operational losses.
- Jump into the full analysis health report here for a deeper understanding of Nanalysis Scientific.
- Understand Nanalysis Scientific's earnings outlook by examining our growth report.
Key Takeaways
- Jump into our full catalog of 902 TSX Penny Stocks here.
- Looking For Alternative Opportunities? Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Nanalysis Scientific might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About TSXV:NSCI
Nanalysis Scientific
Develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally.
Mediocre balance sheet with low risk.
Similar Companies
Market Insights
Weekly Picks

The "Physical AI" Monopoly – A New Industrial Revolution
Czechoslovak Group - is it really so hot?

The Compound Effect: From Acquisition to Integration
Recently Updated Narratives

Rare Pure High Grade Silver with 35% Insider (Near Producer)

Swedens Constellation Software

Inotiv NAMs Test Center
Popular Narratives

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks
Trending Discussion
When was the last time that Tesla delivered on its promises? Lets go through the list! The last successful would be the Tesla Model 3 which was 2019 with first deliveries 2017. Roadster not shipped. Tesla Cybertruck global roll out failed. They might have a bunch of prototypes (that are being controlled remotely) And you think they'll be able to ship something as complicated as a robot? It's a pure speculation buy.
This article completely disregards (ignores, forgets) how far China is in this field. If Tesla continues on this path, they will be fighting for their lives trying to sell $40000 dollar robots that can do less than a $10000 dollar one from China will do. Fair value of Tesla? It has always been a hype stock with a valuation completely unbased in reality. Your guess is as good as mine, but especially after the carbon credit scheme got canned, it is downwards of $150.
